Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Perrone RD"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-10 z 10
    Tytuł:
    Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data
    Autorzy:
    Knight T
    Schaefer C
    Krasa H
    Oberdhan D
    Chapman A
    Perrone RD
    Pokaż więcej
    Temat:
    Medicine (General)
    R5-920
    Therapeutics. Pharmacology
    RM1-950
    Źródło:
    ClinicoEconomics and Outcomes Research, Vol 2015, Iss default, Pp 123-132 (2015)
    Opis pliku:
    electronic resource
    Relacje:
    http://www.dovepress.com/medical-resource-utilization-and-costs-associated-with-autosomal-domin-peer-reviewed-article-CEOR; https://doaj.org/toc/1178-6981
    Dostęp URL:
    https://doaj.org/article/e025e7bbca8a4a4c99c07c362fadafa1  Link otwiera się w nowym oknie
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Establishing a core outcome measure for pain in patients with autosomal dominant polycystic kidney disease: a consensus workshop report.
    Autorzy:
    Natale P; Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
    Perrone RD; Medicine, Nephrology, Clinical and Translational Research Center, Tufts Medical Center and Tufts University School of Medicine, Boston, MA, USA.
    Tong A; Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
    Harris T; Polycystic Kidney Disease International, London, UK.
    Hannan E; Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
    Ju A; Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
    Burnette E; London, UK.
    Casteleijn NF; Department of Urology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
    Chapman A; Department of Nephrology, University of Chicago, Chicago, IL, USA.
    Eastty S; London, UK.
    Gansevoort RT; Department of Nephrology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
    Hogan M; Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, NY, USA.
    Horie S; Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
    Knebelmann B; Service de Nephrologie, Université de Paris, APHP, Hôpital Universitaire Necker, Paris, France.
    Lee R; Armidale, NSW, Sydney, Australia.
    Mustafa RA; Department of Internal Medicine, Division of Nephrology and Hypertension, University of Kansas Medical Centre, Kansas City, KS, USA.
    Sandford R; Academic Department of Medical Genetics, University of Cambridge, Cambridge, UK.
    Baumgart A; Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
    Craig JC; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
    Rangan GK; Centre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia.
    Sautenet B; Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital de Tours, Tours, France.
    Viecelli AK; Australasian Kidney Trials Network, University of Queensland, Brisbane, QLD, Australia.
    Amir N; Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
    Evangelidis N; Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
    Guha C; Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
    Logeman C; Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
    Manera K; Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
    Matus Gonzalez A; Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
    Howell M; Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
    Strippoli GFM; Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
    Cho Y; Australasian Kidney Trials Network, University of Queensland, Brisbane, QLD, Australia.
    Pokaż więcej
    Źródło:
    Clinical kidney journal [Clin Kidney J] 2021 Jul 06; Vol. 15 (3), pp. 407-416. Date of Electronic Publication: 2021 Jul 06 (Print Publication: 2022).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: A systematic review.
    Autorzy:
    Natale P; Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia.; Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia.; Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
    Hannan E; Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia.; Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia.
    Sautenet B; Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital de Tours, Tours, France.; Université de Tours, Université de Nantes, INSERM, SPHERE U1246, Tours, France.
    Ju A; Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia.; Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia.
    Perrone RD; Medicine, Nephrology, Clinical and Translational Research Center, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts, United States of America.
    Burnette E; London, United Kingdom.
    Casteleijn N; Department of Urology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
    Chapman A; Department of Nephrology, The University of Chicago, Chicago, Illinois, United States of America.
    Eastty S; London, United Kingdom.
    Gansevoort R; Department of Urology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
    Hogan M; Division of Nephrology & Hypertension, Department of Internal Medicine Mayo Clinic, Rochester, Minnesota, United States of America.
    Horie S; Department of Urology, Juntendo University, Tokyo, Japan.
    Knebelmann B; Université de Paris APHP, Hôpital Necker, Service de Néphrologie, Paris, France.
    Lee R; Armidale, NSW, Australia.
    Mustafa RA; Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Centre, Lawrence, Kansas, United States of America.
    Sandford R; Academic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom.
    Baumgart A; Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia.; Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia.
    Tong A; Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia.; Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia.
    Strippoli GFM; Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia.; Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
    Craig JC; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
    Rangan GK; Centre for Transplant and Renal Research, Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia.; Department of Medicine, Westmead Hospital, Western Sydney Local Health District, Sydney, NSW, Australia.
    Cho Y; Australasian Kidney Trials Network, University of Queensland, Brisbane, QLD, Australia.; Translational Research Institute, Brisbane, QLD, Australia.; Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2021 May 27; Vol. 16 (5), pp. e0252479. Date of Electronic Publication: 2021 May 27 (Print Publication: 2021).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
    MeSH Terms:
    Patient Reported Outcome Measures*
    Pain/*pathology
    Polycystic Kidney, Autosomal Dominant/*psychology
    Databases, Factual ; Humans ; Pain/etiology ; Polycystic Kidney, Autosomal Dominant/complications ; Polycystic Kidney, Autosomal Dominant/pathology ; Psychometrics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Implications of early diagnosis of autosomal dominant polycystic kidney disease: A post hoc analysis of the TEMPO 3:4 trial.
    Autorzy:
    Janssens P; PKD Research Group, Laboratory of Pediatrics, University Hospitals Leuven, Leuven, Belgium.; Department of Nephrology, University Hospitals Brussels, Brussels, Belgium.
    Jouret F; Division of Nephrology, University of Liège Hospital (ULiège CHU), Liège, Belgium.; Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA), Cardiovascular Sciences, ULiège, Liège, Belgium.
    Bammens B; Department of Microbiology & Immunology, KU Leuven, Leuven, Belgium.; Department of Nephrology, Dialysis and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium.
    Liebau MC; Department of Pediatrics and Center for Molecular Medicine, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.; Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.; Cologne Excellence Cluster on Cellular Stress Responses in Ageing-Associated Diseases (CECAD) and Systems Biology of Ageing Cologne (Sybacol), University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
    Schaefer F; Division of Pediatric Nephrology, University Children's Hospital Heidelberg, Heidelberg, Germany.
    Dandurand A; Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, USA.
    Perrone RD; Division of Nephrology, Tufts Medical Center and Tufts University School of Medicine, Boston, USA.
    Müller RU; Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.; Cologne Excellence Cluster on Cellular Stress Responses in Ageing-Associated Diseases (CECAD) and Systems Biology of Ageing Cologne (Sybacol), University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
    Pao CS; Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, USA.
    Mekahli D; PKD Research Group, Laboratory of Pediatrics, University Hospitals Leuven, Leuven, Belgium. .; Department of Pediatric Nephrology, University Hospitals Leuven, Leuven, Belgium. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2020 Mar 09; Vol. 10 (1), pp. 4294. Date of Electronic Publication: 2020 Mar 09.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Early Diagnosis*
    Glomerular Filtration Rate*
    Quality of Life*
    Polycystic Kidney, Autosomal Dominant/*diagnosis
    Adult ; Case-Control Studies ; Disease Management ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Male ; Polycystic Kidney, Autosomal Dominant/therapy ; Prognosis ; Prospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique study.
    Autorzy:
    Cho Y; Department of Nephrology, Princess Alexandra Hospital.; Australasian Kidney Trials Network, University of Queensland.; Translational Research Institute, Brisbane, Queensland, Australia.
    Sautenet B; Department of Nephrology Hypertension, Dialysis, Kidney Transplantation, Tours Hospital, SPHERE - INSERM 1246, University of Tours and Nantes, Tours, France.
    Gutman T; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.; Centre for Kidney Research, The Children's Hospital at Westmead.
    Rangan G; Centre for Transplant and Renal Research, Westmead Institute for Medical Research, The University of Sydney.; Department of Renal Medicine, Westmead Hospital, Western Sydney Local Health District, Sydney, New South Wales, Australia.
    Craig JC; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
    Ong AC; Academic Nephrology Unit, Department of Infection Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
    Chapman A; Department of Medicine, The University of Chicago, Chicago, Illinois, USA.
    Ahn C; Division of Nephrology, Seoul National University Hospital, Seoul, South Korea.
    Coolican H; Polycystic Kidney Disease Foundation of Australia, Sydney, Australia.
    Kao JT; School of Medicine, Fu Jen Catholic University and Fu Jen Catholic University Hospital.; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
    Gansevoort R; Faculty of Medical Sciences, University Medical Center Gronigen, Gronigen, the Netherlands.
    Perrone RD; Division of Nephrology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, US.
    Harris T; Polycystic Kidney Disease International, London, UK.
    Torres V; Department of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnestota, USA.
    Pei Y; Division of Nephrology and Division of Genomic Medicine, University of Toronto, Toronto, Canada.
    Kerr PG; Department of Nephrology, Monash Medical Centre and Monash University, Melbourne, Victoria, Australia.
    Ryan J; Department of Nephrology, Monash Medical Centre and Monash University, Melbourne, Victoria, Australia.
    Johnson DW; Department of Nephrology, Princess Alexandra Hospital.; Australasian Kidney Trials Network, University of Queensland.; Translational Research Institute, Brisbane, Queensland, Australia.
    Viecelli AK; Department of Nephrology, Princess Alexandra Hospital.
    Geneste C; Department of Nephrology Hypertension, Dialysis, Kidney Transplantation, Tours Hospital, SPHERE - INSERM 1246, University of Tours and Nantes, Tours, France.
    Kim H; Division of Nephrology, Seoul National University Hospital, Seoul, South Korea.
    Kim Y; Division of Nephrology, Seoul National University Hospital, Seoul, South Korea.
    Oh YK; Division of Nephrology, Seoul National University Hospital, Seoul, South Korea.
    Teixeira-Pinto A; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.; Centre for Kidney Research, The Children's Hospital at Westmead.
    Logeman C; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.; Centre for Kidney Research, The Children's Hospital at Westmead.
    Howell M; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.; Centre for Kidney Research, The Children's Hospital at Westmead.
    Ju A; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.; Centre for Kidney Research, The Children's Hospital at Westmead.
    Manera KE; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.; Centre for Kidney Research, The Children's Hospital at Westmead.
    Tong A; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.; Centre for Kidney Research, The Children's Hospital at Westmead.
    Pokaż więcej
    Źródło:
    Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2019 Dec; Vol. 24 (12), pp. 1214-1224. Date of Electronic Publication: 2019 May 02.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Cost of Illness*
    Kidney Failure, Chronic*/etiology
    Kidney Failure, Chronic*/mortality
    Life Style*
    Patient Outcome Assessment*
    Polycystic Kidney, Autosomal Dominant*/diagnosis
    Polycystic Kidney, Autosomal Dominant*/epidemiology
    Polycystic Kidney, Autosomal Dominant*/physiopathology
    Polycystic Kidney, Autosomal Dominant*/psychology
    Quality of Life*
    Attitude to Health ; Australia ; Caregivers/psychology ; Disease Progression ; Evaluation Studies as Topic ; Female ; France ; Humans ; Kidney Function Tests/psychology ; Male ; Middle Aged ; Progression-Free Survival ; Republic of Korea
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-10 z 10

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies